Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

Trisha Wise-Draper, MD, PhD, discusses anticipated data on head and neck cancers and their potential impact on the field.

South Texas is trying to dry out after severe thunderstorms flooded streets and had authorities conducting more than 50 water rescues as many drivers were forced to abandon their vehicles ...

Visby Medicaltm, a leading innovator in medical diagnostics, announced that the U.S. Food and Drug Administration (FDA) has ...

The Health Industry Series (tHIS ASEAN) 2025, one of the biggest medical and healthcare exhibitions in the ASEAN region, will take place from June 9 to 11 at the Kuala Lumpur Convention Centre in ...

Iran’s foreign minister said his country responded to a letter from U.S. President Donald Trump on the prospect of new talks over Tehran’s nuclear program, without giving detail on the ...

CEL-SCI (CVM) announced new data has been published from its prior Phase 3 study of Multikine in newly diagnosed, treatment naive, resectable, ...

During a live event, Sumanta K. Pal, MD, discusses the efficacy and safety findings from the CheckMate 274 trial of adjuvant ...

Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient, surgically resectable endometrial cancer.

Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of Head and Neck Patients.